Military service members and veterans face serious occupational trauma; one element in particular relates to the significantly increased risk of acute and chronic neuropsychiatric conditions.
Neuropsychiatric conditions in the military are particularly impactful because options for treating
credit:
them are limited.
No therapy currently exists that can deliver rapid relief of neuropsychiatric symptoms and is reasonable for use in a broad spectrum of conditions.
Neuropsychiatric conditions are complex, and presentation is highly subject to significant inter-individual variability.
Focused Pharma aims to develop new drugs that target specific neurotransmitter receptor signaling modes to deliver near immediate relief that is generalizable across indications and individuals.